【GC Life Sciences-KY】April 2026 Revenue 42 Million NTD (YoY +31.2%)
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
GC Life Sciences-KY (6431) announced April 2026 revenue of 42 million NTD, showing significant year-over-year growth of 31.2%. This notable increase in the biotechnology and medical sector highlights the company's strong market momentum.